Table 4.
Glucose lowering medications use and medication regimen at admittance and at discharge from the geriatric ward
| Medication | At admittance | At discharge | Pa value | Drug started | Drug discontinued |
|---|---|---|---|---|---|
| Insulin | 70 (32.9) | 71 (33.3) | 0.74 | 4 (1.9) | 5 (2.4) |
| Metformin | 84 (39.4) | 110 (51.6) | < 0.001 | 33 (15.6) | 6 (2.8) |
| Sulfonylurea | 139 (65.3) | 122 (57.3) | 0.01 | 8 (3.8) | 24 (11.3) |
| α-Glucosidase inhibitors | 9 (4.2) | 3 (1.4) | 0.03 | 1 (0.5) | 7 (3.3) |
| Medication regimen | |||||
| Diet alone | – | 15 (7.0) | |||
| Monotherapy | 131 (61.5) | 106 (49.8) | |||
| Sulfonylurea (SU) | 69 (32.4) | 53 (24.9) | |||
| Insulin (I) | 36 (16.9) | 27 (12.7) | |||
| Metformin (M) | 24 (11.3) | 25 (11.7) | |||
| α-Glucosidase inhibitors (A) | 2 (0.9) | 1 (0.5) | |||
| Combination therapy | 82 (38.5) | 92 (43.2) | |||
| SU + M | 44 (20.7) | 47 (22.1) | |||
| SU + I | 17 (8.0) | 6 (2.8) | |||
| M + I | 11 (5.2) | 22 (10.3) | |||
| SU + M + I | 3 (1.4) | 15 (7.0) | |||
| SU + M + A | 2 (0.9) | 1 (0.5) | |||
| I + A | 1 (0.5) | 1 (0.5) | |||
| SU + A | 2 (0.9) | – | |||
| SU + A + I | 2 (0.9) | – | |||
Data are N (%); aWilcoxon signed-rank test